APA
Willekens B., Presas-Rodríguez S., Mansilla M. J., Derdelinckx J., Lee W., Nijs G., De Laere M., Wens I., Cras P., Parizel P., Van Hecke W., Ribbens A., Billiet T., Adams G., Couttenye M., Navarro-Barriuso J., Teniente-Serra A., Quirant-Sánchez B., Lopez-Diaz de Cerio A., Inogés S., Prosper F., Kip A., Verheij H., Gross C. C., Wiendl H., Van Ham M. S., Ten Brinke A., Barriocanal A. M., Massuet-Vilamajó A., Hens N., Berneman Z., Martínez-Cáceres E., Cools N. & Ramo-Tello C. (20200914). Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. : BMJ open.
Chicago
Willekens Barbara, Presas-Rodríguez Silvia, Mansilla M J, Derdelinckx Judith, Lee Wai-Ping, Nijs Griet, De Laere Maxime, Wens Inez, Cras Patrick, Parizel Paul, Van Hecke Wim, Ribbens Annemie, Billiet Thibo, Adams Geert, Couttenye Marie-Madeleine, Navarro-Barriuso Juan, Teniente-Serra Aina, Quirant-Sánchez Bibiana, Lopez-Diaz de Cerio Ascensión, Inogés Susana, Prosper Felipe, Kip Anke, Verheij Herman, Gross Catharina C, Wiendl Heinz, Van Ham Marieke Sm, Ten Brinke Anja, Barriocanal Ana Maria, Massuet-Vilamajó Anna, Hens Niel, Berneman Zwi, Martínez-Cáceres Eva, Cools Nathalie and Ramo-Tello Cristina. 20200914. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. : BMJ open.
Harvard
Willekens B., Presas-Rodríguez S., Mansilla M. J., Derdelinckx J., Lee W., Nijs G., De Laere M., Wens I., Cras P., Parizel P., Van Hecke W., Ribbens A., Billiet T., Adams G., Couttenye M., Navarro-Barriuso J., Teniente-Serra A., Quirant-Sánchez B., Lopez-Diaz de Cerio A., Inogés S., Prosper F., Kip A., Verheij H., Gross C. C., Wiendl H., Van Ham M. S., Ten Brinke A., Barriocanal A. M., Massuet-Vilamajó A., Hens N., Berneman Z., Martínez-Cáceres E., Cools N. and Ramo-Tello C. (20200914). Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. : BMJ open.
MLA
Willekens Barbara, Presas-Rodríguez Silvia, Mansilla M J, Derdelinckx Judith, Lee Wai-Ping, Nijs Griet, De Laere Maxime, Wens Inez, Cras Patrick, Parizel Paul, Van Hecke Wim, Ribbens Annemie, Billiet Thibo, Adams Geert, Couttenye Marie-Madeleine, Navarro-Barriuso Juan, Teniente-Serra Aina, Quirant-Sánchez Bibiana, Lopez-Diaz de Cerio Ascensión, Inogés Susana, Prosper Felipe, Kip Anke, Verheij Herman, Gross Catharina C, Wiendl Heinz, Van Ham Marieke Sm, Ten Brinke Anja, Barriocanal Ana Maria, Massuet-Vilamajó Anna, Hens Niel, Berneman Zwi, Martínez-Cáceres Eva, Cools Nathalie and Ramo-Tello Cristina. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. : BMJ open. 20200914.